Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
昊华科技2024年商誉
Type of publications
Guidelines (1)
NITAG documentation (44)
SAGE documentation (8)
Systematic reviews (SYSVAC) (327)
Regions
Africa (29)
Americas (23)
Eastern Mediterranean (6)
Europe (32)
South-East Asia (5)
Western Pacific (14)
Diseases
Chikungunya (1)
Cholera (3)
COVID-19 (125)
Dengue (4)
Diphtheria (4)
Ebola (1)
Haemophilus influenzae type B (3)
Hepatitis A (1)
Hepatitis B (12)
Hepatitis E (2)
Herpes zoster (9)
Human papillomavirus (HPV) (50)
Influenza (51)
Malaria (4)
Measles (12)
Meningococcal disease (9)
Moraxella catarrhalis (1)
Mpox (16)
Mumps (1)
Pertussis (9)
Pneumococcal disease (17)
Poliomyelitis (5)
Rabies (1)
Rotavirus (4)
RSV (Respiratory syncytial virus) (22)
Rubella (2)
Salmonella (1)
Tetanus (5)
Tuberculosis (4)
Typhoid (3)
Varicella (3)
Yellow fever (2)
Show more
380 results found
2024
∙
Alie, M. S. Abebe, G. F. Negesse, Y. Adugna, A. Girma, D.
Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis
2024
∙
Suares, J. E. Khan, S. Aadrika, A. Poojari, P. G. Rashid, M. Thunga, G.
Vaccine-associated paralytic poliomyelitis in oral polio vaccine recipients: disproportionality analysis using VAERS and systematic review
2024
∙
Wroblewski, D. Brust-Sisti, L. A. Bridgeman, M. Bridgeman, M. B.
Vaccines for Respiratory Syncytial Virus Prevention in Older Adults
2024
∙
Liu, J. Liu, S. Yu, S. Du, X. Hao, J. Hui, R. Buh, A. Chen, W. Chen, J.
Willingness to receive mpox vaccine among men who have sex with men: a systematic review and meta-analysis
2024
∙
SAGE
Smallpox and mpox (orthopoxviruses): WHO position paper, August 2024
2024
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, March 2024: conclusions and recommendations
2024
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, September 2024: conclusions and recommendations
2024
∙
Haute Autorité de Santé
Transition of INFLUVAC influenza vaccine from its quadrivalent form to a trivalent form in the seasonal influenza vaccination strategy in France
2024
∙
NACI
Recommendations on the use of pneumococcal vaccines in adults, including PNEU-C-21
2024
∙
ACIP
New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, October 2024
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register